力生制药 (002393)

TIANJIN LISHENG PHARMACEUTICAL CO.,LTD.

ASZ

Tags

Specialized-Sophisticated-Distinctive-Innovative EnterprisesCSI Share Buyback IndexInnovative DrugsPharmaceutical ManufacturingSynthetic BiologySmall Cap State-Owned EnterprisesNuclear Pollution Prevention and ControlBiological VaccinesHigh-Performing StocksVitaminsHepatitis ConceptMargin Trading and Securities Lending

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 25761.69
  • Circulating A-Shares(W): 25101.68
  • Earnings Per Share(RMB): 1.4400
  • Net Assets Per Share(RMB): 19.2839
  • Operating Revenue(W RMB): 100728.04
  • Total Profit(W RMB): 43301.48
  • Net Profit Attributable to Parent(W RMB): 37074.04
  • Net Profit Growth Rate(%): 119.05
  • Weighted Return on Equity(%): 7.6800
  • Operating Cash Flow Per Share(RMB): 0.4840
  • Undistributed Profit Per Share(RMB): 6.7378
  • Capital Reserve Per Share(RMB): 6.2701

2. Main Business

The main business covers:

  • Research, development, production and sales of pharmaceutical products

3. Company Basic Information

  • Company Name: Tianjin Lisheng Pharmaceutical Company Ltd.
  • Listing Date: 2010-04-23
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 16, Saida North First Road, Xiqing Economic and Technological Development Zone, Tianjin, China
  • Website: www.lishengpharma.com
  • Company Profile：On July 27, 2001, the Tianjin Municipal Finance Bureau approved the equity structure plan of the aforementioned promoters with document Jin Cai Qi Yi [2001] No. 77. On August 3, 2001, the Tianjin Municipal People's Government issued document Jin Gu Pi [2001] No. 9 "Approval on the Establishment of Tianjin Lisheng Pharmaceutical Co., Ltd.", approving the establishment of the joint stock company. On August 8, 2001, the issuer registered with the Tianjin Administration for Industry and Commerce, obtained the "Business License of Enterprise Legal Person", with a registered capital of 136,454,992 yuan.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Tianjin Jinhao Pharmaceutical Co., Ltd. General Legal Person 13119.49 52.41
2 Tianjin Xiqing Economic Development Group Co., Ltd. General Legal Person 182.21 0.73

5. Concept Sectors

  • Biological Vaccine
  • Vitamin
  • Nuclear Pollution Control
  • Hepatitis Concept
  • Innovative Drug
  • Synthetic Biology
  • Margin Trading & Securities Lending
  • High-Performance Stock
  • Specialized, Refined, Distinctive, and Innovative SME
  • Small-Cap State-Owned Enterprise
  • CSI Buyback Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information